Insight Molecular Diagnostics Inc. (IMDX) Total liabilities 2015–2025
Insight Molecular Diagnostics Inc. (IMDX) total liabilities at each fiscal year-end, per SEC filings.
$57.2MFY2025 · since FY2015: $2.3M → $57.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $57.2M | +20.8% |
| FY2024 | $47.4M | -3.9% |
| FY2023 | $49.3M | -18.5% |
| FY2022 | $60.5M | -35.9% |
| FY2021 | $94.3M | +330.1% |
| FY2020 | $21.9M | — |
| FY2015 | $2.3M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice